Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transcriptional Profiles Predict Disease Outcome in Patients with Cutaneous T-Cell Lymphoma
Ivan V. Litvinov, David A. Jones, Denis Sasseville, et al.
Clinical Cancer Research (2010) Vol. 16, Iss. 7, pp. 2106-2114
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
Karen M. VanderMolen, William McCulloch, Cedric J. Pearce, et al.
The Journal of Antibiotics (2011) Vol. 64, Iss. 8, pp. 525-531
Open Access | Times Cited: 281
Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
Anita G. Seto, Xuan Beatty, Joshua M. Lynch, et al.
British Journal of Haematology (2018) Vol. 183, Iss. 3, pp. 428-444
Open Access | Times Cited: 248
Evolving Insights in the Pathogenesis and Therapy of Cutaneous T‐cell lymphoma (Mycosis Fungoides and Sezary Syndrome)
Henry K. Wong, Anjali Mishra, Timothy S. Hake, et al.
British Journal of Haematology (2011) Vol. 155, Iss. 2, pp. 150-166
Open Access | Times Cited: 144
Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Julia Scarisbrick, Y.H. Kim, Sean Whittaker, et al.
British Journal of Dermatology (2014) Vol. 170, Iss. 6, pp. 1226-1236
Closed Access | Times Cited: 138
Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In Vivo
Xuesong Wu, Brian Schulte, Youwen Zhou, et al.
Journal of Investigative Dermatology (2014) Vol. 134, Iss. 11, pp. 2814-2822
Open Access | Times Cited: 122
High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides
Adèle de Masson, John T. O’Malley, Christopher P. Elco, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 440
Open Access | Times Cited: 111
Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators
Ivan V. Litvinov, Michael T. Tetzlaff, P Thibault, et al.
OncoImmunology (2017) Vol. 6, Iss. 5, pp. e1306618-e1306618
Open Access | Times Cited: 87
Molecular Markers of Early-Stage Mycosis Fungoides
Yaohua Zhang, Yang Wang, Richard Yu, et al.
Journal of Investigative Dermatology (2012) Vol. 132, Iss. 6, pp. 1698-1706
Open Access | Times Cited: 102
A Meta-Analysis of Gene Expression Data Identifies a Molecular Signature Characteristic for Tumor-Stage Mycosis Fungoides
Marloes S. van Kester, Martin K. Borg, Willem H. Zoutman, et al.
Journal of Investigative Dermatology (2012) Vol. 132, Iss. 8, pp. 2050-2059
Open Access | Times Cited: 86
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
Thorbjørn Krejsgaard, Ivan V. Litvinov, Yang Wang, et al.
Blood (2013) Vol. 122, Iss. 6, pp. 943-950
Open Access | Times Cited: 85
Comprehensive analysis of cutaneous T‐cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy
Feras M. Ghazawi, Elena Netchiporouk, Elham Rahme, et al.
Cancer (2017) Vol. 123, Iss. 18, pp. 3550-3567
Open Access | Times Cited: 83
The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)
Ivan V. Litvinov, Elena Netchiporouk, Brendan Cordeiro, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 12, pp. 2820-2829
Open Access | Times Cited: 77
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines
Ivan V. Litvinov, Brendan Cordeiro, Simon Fredholm, et al.
Cell Cycle (2014) Vol. 13, Iss. 18, pp. 2975-2982
Open Access | Times Cited: 70
The discovery and development of romidepsin for the treatment of T-cell lymphoma
Piotr Smolewski, Tadeusz Robak
Expert Opinion on Drug Discovery (2017), pp. 1-15
Closed Access | Times Cited: 70
Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2014) Vol. 89, Iss. 8, pp. 837-851
Open Access | Times Cited: 67
A three‐signal model of T‐cell lymphoma pathogenesis
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 113-122
Open Access | Times Cited: 67
The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review
Brandon Ramchatesingh, Amelia Martínez Villarreal, Domenico Arcuri, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12622-12622
Open Access | Times Cited: 35
Cutaneous T‐cell lymphoma: 2011 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2011) Vol. 86, Iss. 11, pp. 928-948
Open Access | Times Cited: 71
Deficient Cutaneous Antibacterial Competence in Cutaneous T-Cell Lymphomas: Role of Th2-Mediated Biased Th17 Function
Kerstin Wolk, Hiroshi Mitsui, Katrin Witte, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 21, pp. 5507-5516
Open Access | Times Cited: 65
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis
Yuanshen Huang, Ivan V. Litvinov, Yang Wang, et al.
Oncotarget (2014) Vol. 5, Iss. 12, pp. 4418-4425
Open Access | Times Cited: 61
Resimmune, an anti-CD3 recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma
Arthur E. Frankel, Jung hui Woo, Chul Ahn, et al.
Haematologica (2015) Vol. 100, Iss. 6, pp. 794-800
Open Access | Times Cited: 51
Demographic patterns of cutaneous T‐cell lymphoma incidence in Texas based on two different cancer registries
Ivan V. Litvinov, Michael T. Tetzlaff, Elham Rahme, et al.
Cancer Medicine (2015) Vol. 4, Iss. 9, pp. 1440-1447
Open Access | Times Cited: 50
CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis
Ivan V. Litvinov, Albane A. Bizet, Yousef Binamer, et al.
Experimental Dermatology (2011) Vol. 20, Iss. 8, pp. 627-632
Closed Access | Times Cited: 60
Identification of geographic clustering and regions spared by cutaneous T‐cell lymphoma in Texas using 2 distinct cancer registries
Ivan V. Litvinov, Michael T. Tetzlaff, Elham Rahme, et al.
Cancer (2015) Vol. 121, Iss. 12, pp. 1993-2003
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top